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Sj16 is an anti-inﬂammatory protein identiﬁed from Schistosoma japonicum. Our previous studies showed that recombinant Sj16
(rSj16) could suppress host’s inﬂammatory responses and inhibit macrophage maturation. In the present study, the eﬀects of rSj16
on the diﬀerentiation of the murine myeloid leukemia WEHI-3B JCS cell line and on mouse hematopoiesis were investigated.
Our data demonstrated that rSj16 expressed and puriﬁed from Escherichia coli could suppress the proliferation of the WEHI-3B
JCS cells in a time- and concentration-dependent manner, while not aﬀect the viability of the cells. Further studies indicated that
rSj16 induced macrophage diﬀerentiation of the WEHI-3B JCS cells, and arrested the cell cycle in the G1/G0 and G2/M phases.
The macrophage diﬀerentiation of the rSj16-treated WEHI-3B JCS cells was conﬁrmed by their expression of macrophage speciﬁc
antigen F4/80 and phagocytic activity. Furthermore, our results revealed that rSj16 biased the colony formation of mouse bone
marrow cells towards macrophage linage.
1.Introduction
Leukemia occurs when the normal hematopoietic process
fails, and the leukemic cells retain the proliferative capacity
of progenitor cells and unable to spontaneously undergo
terminal maturation [1]. The cell line WEHI-3B JCS is a
D-subclone isolated from the WEHI 3B myelomonocytic
leukemia cell line [2]. Previous studies have reported that
monocytic diﬀerentiation of this cell line could be induced
by phorbol myristate acetate (PMA) [2], biochanin A [3],
and conjugated linoleic acid [4], and that endogenous IL-1α,
IL-1β,andTNF -αhavebeenshowntoplayanimportantrole
during these diﬀerentiation-inducing processes.
Schistosome, the causative agent of schistosomiasis in
the world, is a blood born ﬂuke (trematode) of the genus
Schistosoma. Plenty of studies have demonstrated that the
schistosome-originatedsubstancescouldmodulatethehost’s
immune system [5, 6]. For example, the prostaglandin
D2 from schistosome has been well known to block the
migration of langerhans cells to the draining lymph nodes,
therebyinhibiting acrucialstepintheinitiationofimmunity
[7]. An IL-4 inducing factor identiﬁed from Schistosoma
mansoni (S. mansoni) egg has been demonstrated to skew the
immune response to Th2 [8]. Another apoptosis inducing
factor produced by skin-stage schistosomula of S. mansoni
could cause apoptosis of T cells [9]. Trottein et al. have also
reported that substances from S. mansoni suppressed host’s
inﬂammation by activating host microvascular endothelial
cells [10]. However, up to now, little is reported about
the immunomodulatory eﬀects of schistosome-derived sub-
stances on leukemia and hematopoiesis.
Recently, we have cloned a gene named Sj16 from
Schistosoma japonicum (S. japonicum) and demonstrated
that the recombinant Sj16 (rSj16) expressed and puriﬁed2 Journal of Biomedicine and Biotechnology
from Escherichia coli (E. coli) could suppress the recruit-
ment of mature macrophages into the peritoneal cavity in
thioglycollate-induced inﬂammation in BALB/c mice [11].
In the present study, we reported the eﬀects of rSj16 on the
proliferation and diﬀerentiation of the WEHI-3B JCS and on
mouse hematopoiesis.
2.MaterialsandMethods
2.1.CellLine. Themurine myeloidleukemiacelllineWEHI-
3B JCS [2] was cultured in RPMI 1640 medium (Gibco-
BRL, USA) supplemented with 10mM L-glutamine, 10%
fetal calf serum (FCS; HyClone, USA), and 1% antibiotics
mixture(100unit/mlpenicillin,100μg/mlstreptomycin,and
0.25μg/ml amphotericin B; GibcoBRL, USA). The cultures
were incubated under a humidiﬁed atmosphere of 95% air,
5% CO2 at 37
◦C.
2.2. Animals. BALB/c mice (female, 4–6 week), bred and
kept by the Laboratory Animal Services Centre of the
Chinese University of Hong Kong, were used. All animal
procedures were approved by the Animal Experimentation
Ethics Committee (CUHK) in accordance with the Depart-
ment of Health (Hong Kong) guidelines in Care and Use of
Animals.Allexperimentswereperformedunderlicencefrom
the Hong Kong Special Administrative Region Government.
2.3. Expression and Puriﬁcation of Recombinant Proteins. The
recombinant Sj16 (rSj16) and recombinant glutathione-S-
transferase(rGST)wereexpressedandpuriﬁedfromE.colias
we have described before [11]. The puriﬁed rSj16 and rGST
were passed through a Detoxi-Gel AﬃnityPak polymyxin
B column (Pierce, USA) to eliminate endotoxins. The
absence of endotoxins in the proteins was further conﬁrmed
by Limulus amebocyte lysate test (sensitivity 0.25EU/ml,
Associates of Cape Cod, USA) before the proteins were used
in functional assays.
2.4. Cell Proliferation Assessment. The colorimetric 3-(4, 5-
dimethylthiazolyl-2)-2,5-diphenyltetrazoliumbromide(MTT)
assaywasemployedtoquantifythecellproliferation[12,13].
Brieﬂy, WEHI-3B JCS cells were incubated with RPMI 1640
medium containing serially diluted rSj16 or rGST in 96-
well microplates (Nunc, Denmark) for 24hours, 48hours,
72 hours, and 96 hours. 20μlM T T( 5m g / m ls t o c ks o l u t i o n ,
Sigma, USA) were then added into each well and incubated
for 4 hours, and the plates were centrifuged at 500×gf o r
10minutes. The MTT solution was removed and replaced by
150μlDMSO,andtheplateswereshakenuntiltheformazans
were thoroughly dissolved. The optical density was deter-
mined using a microplate reader (Dynatech Laboratories,
USA) at a wavelength of 570nm. Each assay was performed
in triplicate.
2.5.CellViability. Cellviabilitywasdeterminedusingtrypan
blue exclusion assay. Brieﬂy, WEHI-3B JCS cells were incu-
bated with RPMI 1640 medium in the presence or absence
of 0.5μg/ml rSj16 or 0.5μg / m lr G S Tf o r2 4h o u r s ,4 8h o u r s ,
and 72 hours. The cells were then collected and mixed 1 : 1
with 0.4% trypan blue (Sigma, USA). The percentage of
viable cells was recorded within 10 minutes with an inverted
microscope.Greaterthan300cellspersamplewereexamined
and the data were expressed as percentage (%) viability. The
experiment was performed in triplicate.
2.6. Cell Cycle Analysis. Cell cycle analysis was performed
on WEHI-3B JCS cells incubated for 1–4 days with either
rSj16 (0.5μg/ml) or rGST (0.5μg/ml). The cells were ﬁxed
in chilled ethanol overnight before staining with propidium
iodide staining solution (3.8mM sodium citrate, 50μg/ml
propidium iodide, 50μg/ml RNase A in PBS) at room
temperature for 30minutes. Analysis was performed imme-
diately after staining using a FACScan (Becton Dickinson,
USA) and CELLFit program (Becton Dickinson, USA).
2.7. Analysis of WEHI-3B JCS Diﬀerentiation. WEHI-3B
JCS cells were cultured with either rGST (0.5μg/ml) or
rSj16 (0.5μg/ml) in the presence/absence of serially diluted
neutralizing anti-IL-1α, anti-IL-1β, anti-TNF-α, or these
three antibodies together (R&D Systems, USA) for up to
72hours.
Theadherentandsuspensioncellswerecollected,respec-
tively, and counted with a hemacytometer (Bright-line,
Sigma, USA) 24, 48, and 72 hours after treatment. The
percentage of adherent cells was calculated. The culture
supernatants after 24, 48, and 72 hours treatment were
collected, stored at −80
◦C until cytokine measurement.
The morphology of the WEHI-3B JCS cells was stud-
ied up to 72 hours of treatment using a phase-contrast
microscope (Nikon, Japan). Monocytic diﬀerentiation of
the treated cells was also examined using modiﬁed Wright-
Giemsastain(Sigma,USA)aftercytospinsmearpreparation.
All experiments were independently done at least 3 times.
Expression of cell surface antigens was determined by
ﬂow cytometry 72 hours after treatment. After twice washing
with FACS medium (2% heat-inactivated FCS and 0.05%
sodium azide in PBS), cells were incubated at 4◦Cf o r
30minutes with antimouse FcγR antibody (CD16/CD32,
eBioscience, USA). The cells were then washed twice and
incubated at 4◦Cf o r3 0 m i n u t e sw i t ha ﬃnity puriﬁed
antimouse F4/80 or antimouse Gr-1 antibodies (both
fromeBioscience,USA).Isotype-matchedcontrolantibodies
(eBioscience, USA) were used as negative controls. Unbound
antibodies were removed by washing the cells twice with
FACS medium. The cells were then stained with FITC-
conjugated sheep antirat IgG (BD PharMingen, USA) at 4◦C
for 30minutes and then washed and ﬁxed with 1% (w/v)
paraformaldehyde in PBS. Cells were analyzed by a FACScan
(Becton Dickinson, USA).
Phagocytic activity of WEHI-3B JCS was determined by
themodiﬁedyeastphagocytosisassayasdescribedpreviously
[2, 3]. Brieﬂy, opsonized yeasts were prepared by incubating
heat-inactivated yeast cells (Saccharomyces cerevisiae)w i t h
fresh mouse serum at 37
◦C for 30 minutes. 2 × 107
opsonized yeasts were added to untreated, 72 hours post
rSj16 or rGST treated WEHI-3B JCS cell cultures in 6-wellJournal of Biomedicine and Biotechnology 3
microplates (Nunc, Denmark). The mixtures were incubated
at 37
◦C for 16 hours, and the percentages of phagocytic cells
were counted under microscope. Cells with a minimum of
three ingested yeasts were considered positive. A total of 500
cells were counted in each sample.
2.8. Cytokine Determination. Levels of IL-1α,I L - 1 β,a n d
TNF-α in the culture supernatants were measured using
DuoSet ELISA Development kit (R&D Systems, USA)
according to the manufacturer’s protocol. Brieﬂy, 96-well
Maxisorp multititer plates (Nunc, Denmark) were coated
overnight at 4◦C with appropriate capture antibodies
(2μg/mlforanti-IL-1α,4μg/mlforanti-IL-1β,and0.8μg/ml
for anti-TNF-α) in PBS at pH 7.4 and then washed three
times with PBS containing 0.05% Tween 20. The plates were
blocked for 2 hours at room temperature with 1% BSA in
PBS, followed with three washes as described above. Serially
dilutedmurinerecombinantcytokinestandardsIL-1α(1.95–
1,000pg/ml), IL-1β (1.95–1,000pg/ml), or TNF-α (3.91–
1,000pg/ml) and the culture supernatants were then added
in duplicate and incubated for 2 hours at room temperature.
After three washes, the plates were incubated for 2 hours
at room temperature with appropriate biotinylated detec-
tion antibodies and then washed again. To detect biotiny-
lated antibodies, streptavidin-linked horseradish peroxidase
(1/1,000 dilution) was added and incubated for 20minutes
in the dark at room temperature. After a ﬁnal washing of
ﬁve times, 3, 3 ,5 ,5  -tetramethylbenzidine liquid substrate
(Sigma, USA) was added to each well. The absorbance was
read at 450nm with the wavelength correction at 570nm
usingamicroplatereader(DynatechLaboratories,USA),and
the concentration of the samples was calculated using the
standard curve.
2.9. IL-1α,I L - 1 β,a n dT N F - α Neutralization Assay (by MTT
Assay). For neutralization assay, WEHI-3B JCS cells were
incubated in 96-well microplates (Nunc) with RPMI 1640
medium containing 0.5μg/ml rSj16 in the presence or
absence of serially diluted neutralizing anti-IL-1α, anti-IL-
1β, anti-TNF-α, or these three antibodies together (R&D
Systems) for 72 hours. To test whether anti-IL-1α, anti-
IL-1β, or anti-TNF-α antibody itself aﬀects the WEHI-3B
JCS proliferation, WEHI-3B JCS cells were also incubated
in 96-well microplates (Nunc) with RPMI 1640 medium
containing serially diluted anti-IL-1α, anti-IL-1β or anti-
TNF-α antibody (R&D Systems). 20μlM T T( 5m g / m ls t o c k
solution, Sigma, USA) were then added into each well and
incubated for 4h, and the proliferation was assessed as men-
tioned above. Each assay was performed in triplicate. The
results of neutralization assay were expressed as proliferation
index which was calculated as following: proliferation index
= mean O.D.570 of triplicate wells containing 0.5μg/ml
rSj16 in the presence of neutralizing anti-IL-1α, anti-IL-1β,
or anti-TNF-α antibodies/mean O.D.570 of triplicate wells
containing 0.5μg/ml rSj16 in the absence of neutralizing
anti-IL-1α, anti-IL-1β, or anti-TNF-α antibodies.
2.10. Mouse Bone Marrow Cell Colony-Forming Unit Assay.
FemaleBALB/cmiceweresacriﬁcedandwetthoroughlywith
70% ethanol. The femurs were isolated, the bone marrows
were ﬂushed out, and the single cell suspension was then
prepared. To measure the number of nucleated cells, 10μl
of the single cell suspension was ﬁrst diluted in 490μlo f
3% acetic acid and then counted using a hemacytometer
(Bright-line, Sigma, USA). The cell suspension was adjusted
to 5 × 106 nucleated cells per ml with cold RPMI-1640
medium.
The bone marrow cell suspension was added into
prewarmed RPMI-1640 medium containing 20% FCS
(HyClone), 2% antibiotics mixture (GibcoBRL), and 0.33%
agar (cell culture tested; sigma, USA), and mixed well (60μl
of cell suspension per 6ml of medium). The mixture was
transferred into 24-well plates (Nunc), 0.4ml per well, and
then kept at room temperature for 15 minutes to allow the
agar solidiﬁcation. After solidiﬁcation, 25μl of PBS alone,
25μl of PBS containing 0.5μg/ml of rSj16 or 0.5μg/ml rGST
was added into corresponding wells and incubated in a
humidiﬁed 37
◦C incubator for one hour, followed by adding
25μl of PBS, 25μl of PBS containing 0.5ng/ml of IL-3,
25μl of PBS containing 36ng/ml of M-CSF, or 25μl of PBS
containing 12ng/ml of G-CSF into corresponding wells and
incubated for further seven days. Each semisolid agar gel was
then transferred onto a cleaning glass slide, covered with
3 layers of Whatman ﬁlter papers, and dried overnight at
37
◦Coven.Theslideswerestainedwithhematoxylinsolution
(Sigma, USA), and the cell colonies of greater than 40 cells
were counted. All samples were run in triplicate.
2.11. Statistics. Comparisons of data within experiments
were tested for signiﬁcance using the Student’s t-test.
3. Results
3.1. rSj16 Inhibited WEHI-3B JCS Cell Proliferation. In
this study, rSj16 was ﬁrst expressed and puriﬁed as a
rGST-rSj16 fusion protein using the prokaryotic expression
vector pGEX-4T-1, and the rGST tag was then removed
by thrombin digestion to release free rSj16 [11]. However,
during puriﬁcation of free rSj16, traces of rGST may not be
absolutely excluded from the rSj16 solution. On the other
hand, the rGST tag in vector pGEX-4T-1 is also S. japonicum
originated [14] .T h e s em a d er G S Ta ni d e a lc o n t r o lp r o t e i n
during the rSj16 functionary assays. Thus, the rGST was
puriﬁed and used as a control protein throughout the study.
The antiproliferative eﬀe c to fr S j 1 6w a se v a l u a t e db y
MTT assay. Data were expressed as the percentage inhibition
by the ratio of each absorbance relative to the absorbance of
the nontreated control, multiplied by 100%. A concentration
(Figure 1(a))a n dt i m e( Figure 1(b)) dependent inhibition
of rSj16 on WEHI-3B JCS cell growth was observed at 48
hours (more than 10% inhibition) and persisted until 96h.
rSj16 inhibited the proliferation of WEHI-3B JCS cells at a
maximal eﬀect of more than 40% at 72hours, and reached
this maximal eﬀect at the concentration of 0.5μg/ml or
higher(Figure 1(a)).Thus,inthefollowingpartofthisstudy,
0.5μg/ml of rSj16 was used. rGST did not show signiﬁcant
eﬀect on the proliferation of WEHI-3B JCS cells when being
used as high as 5μg/ml (data not shown).4 Journal of Biomedicine and Biotechnology
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Figure 1: Antiproliferative eﬀect of rSj16 on WEHI-3B JCS cells. WEHI-3B JCS cells were incubated with 0.2ml of medium containing
diﬀerent doses of rSj16 for 72 hours (a) or containing 0.5μg/ml of rSj16 for up to 96 hours (b). The proliferation was quantiﬁed by MTT
assay.
In order to test whether the suppression of WEHI-3B
J C Sp r o l i f e r a t i o nb yr S j 1 6i sd u et oi t sc y t o t o x i ce ﬀect on
the cells, WEHI-3B JCS cells were incubated with rSj16 for
up to 72hours and the cell viability was assessed by trypan
blueexclusionassay.Theresultsindicatedthattheviabilityof
WEHI-3B JCS cells was not aﬀected after 0.5μg/ml of rSj16
treatment for 24 hours (98.51 ± 0.14% versus 98.86 ± 0.28%
viability, P>. 2; rSj16 treatment versus untreated; n = 4),
48 hours (97.80% ± 0.35% versus 97.36 ± 0.43%, P>. 2;
n = 4) and 72 hours (96.48% ± 0.57% versus 97.43% ±
0.51%, P>. 2; n = 4). rGST did not show any eﬀects on
WEHI-3B JCS viability (data not shown).
3.2. Eﬀect of rSj16 on the WEHI-3B JCS Cell Cycle. Because
rSj16 exerted signiﬁcant eﬀect on WEHI-3B JCS cells
proliferation (Figure 1), while it did not aﬀect the viability
of the cells (see above), we were interested in studying the
pattern of cell cycle distribution of rSj16-treated cells. The
cell cycle distribution was assessed by ﬂow cytometry after
treatment with rSj16 for various times.
A signiﬁcant accumulation of WEHI-3B JCS cells in
the G1/G0 phases of the cell cycle occurred at 24 hours
(Figure 2(a)),reachedthepeakat72hours(Figure 2(c)),and
retained a high level at 96 hours (Figure 2(d)), after treat-
ment with 0.5μg/ml of rSj16, companied witha concomitant
decrease in the proportion of those in S phase (Figures 2(c)
and 2(d)). A signiﬁcant accumulation of WEHI-3B JCS cells
in the G2/M phase of the cell cycle also occurred at 48hours
(Figure 2(b)), and reached the peak at 72hours (Figure 2(c))
post 0.5μg/ml of rSj16 treatment. After 72h, the accumu-
lation of G1/G0 and G2/M population did not increase
anymore even exposure for longer time (Figure 2(d)). rGST
had no eﬀect on the cell cycle distribution of WEHI-3B JCS
cells (Figures 2(a)–2(d)).
3.3. Morphological Study of rSj16-Treated WEHI-3B JCS Cells.
The eﬀect of rSj16 on morphology of WEHI-3B JCS cells
was studied in a time course of 72h. The WEHI-3B JCS cells
becameadherentanddevelopedpseudopodiainthepresence
of 0.5μg/ml of rSj16 (Figures 3(a) and 3(b)). Aggregation
of the WEHI-3B JCS cells to each other followed by the
adherence of the cells to the plate was observed within 24
hours of rSj16 exposure (Figures 3(a) and 3(b)). By the time
of 48h, more than 50% of the cells attached to the plate
and began to form pseudopodia (Figures 3(a) and 3(b)).
After 72hours of rSj16 exposure, 71.28% ± 3.15% of the
cells were adherent to the plate, and over 50% of the cells
had pseudopodia and cytoplasmic vacuoles (Figures 3(a)
and 3(b)). All of these morphological changes indicated that
rSj16 may induce macrophage diﬀerentiation of WEHI-3B
JCS cells, as the abilities to develop prominent pseudopodia
and adhere to charged surface are typical features of normal
tissue macrophages [15, 16]. In contrast, cells exposed with
rGST (0.5μg/ml) did not developed signiﬁcant adhesion
(only0.02% ±0.007%ofthecellswereadherentat72h)and
pseudopodia formation (Figures 3(a) and 3(b)).
To further characterize the morphological changes,
cytospin smear of WEHI-3B JCS cells treated with rSj16
or rGST was prepared and stained with Modiﬁed Wright-
Giemsa stain (Sigma, USA). The result showed that after
72 hours exposure to 0.5μg/ml of rSj16, the nuclear:
cytoplasmic ratio of the cells reduced, the nuclear chromatin
became condensed and eccentrically placed, the cytoplasmic
borderswereprotruded,andcytoplasmicvacuoleswereoften
present (Figure 3(e)). These morphological features were
similar to those described for mature tissue macrophages
[15–17]. WEHI-3B JCS cells treated with rGST did not
exhibit signiﬁcant morphological changes (Figure 3(d)).
3.4. Expression of Macrophage Marker on rSj16 Induced
WEHI-3B JCS Cells. To conﬁrm the macrophage
diﬀerentiation-inducing activity of rSj16 on WEHI-3B
JCS cells, ﬂow cytometric analysis was carried out to
examine for the expression of diﬀerentiation antigens byJournal of Biomedicine and Biotechnology 5
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Figure 2: Modulation of WEHI-3B JCS cell cycle by rSj16. WEHI-3B JCS cells were cultured for one day (a), two days (b), three days (c),
and four days (d) in the presence of 0.5μg/ml of rSj16 (rSj16), 0.5μg/ml of rGST (rGST), or medium alone (untreated), and the cell cycle
status was analyzed by ﬂow cytometry. Data indicate mean ± SEM of three independent experiments.
∗P<. 1;
∗∗P<. 01;
∗∗∗P<. 001 as
compared with that of untreated group.
rSj16-treated cells. Untreated WEHI-3B JCS cells expressed
little F4/80+ and Gr-1+ (Figure 4). 72 hours exposure of
WEHI-3B JCS cells to rSj16 (0.5μg/ml) resulted in nearly
40% increase in the expression of the antigen F4/80+, while
there were no signiﬁcant changes on the expression of Gr-1+
(Figure 4). rGST did not show signiﬁcant eﬀect on the
expression of these antigens (Figure 4).
3.5. rSj16 Induced WEHI-3B JCS Cells Showed Phagocytic
Activity. A key function of normal mononuclear phagocytes
is ingestion of foreign materials. The biological function of
rSj16-treated WEHI-3B JCS cells was therefore measured by
their capacity of yeast phagocytosis. The results indicated
that WEHI-3B JCS cells developed the ability to eﬃciently
phagocytose Saccharomyces cerevisiae after rSj16 exposure
(Figures 5(a)–5(c)). More than 50% of the WEHI-3B JCS
cells ingested three or more yeast cells after cultured in the
presence of 0.5μg/ml rSj16 for 3 days (Figure 5(d)). Less
than2%oftheuntreatedorrGST-treatedWEHI-3BJCScells
phagocytized yeast cells.
3.6. Up-Regulation of IL-1α,I L - 1 β,a n dT N F - α Expression in
rSj16-Treated WEHI-3B JCS Cells. Previous studies reported
that TNF-α could induce monocytic diﬀerentiation of
WEHI-3B JCS cells [2], and that IL-1α and IL-1β were
involved in the diﬀerentiation-inducing activity of TNF-α6 Journal of Biomedicine and Biotechnology
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Figure 3: Eﬀect of rSj16 on adherence and morphology of WEHI-3B JCS cells. WEHI-3B JCS cells were treated with 0.5μg/ml rSj16 (rSj16),
0.5μg/ml rGST (rGST), or medium alone (untreated) for various time periods, and morphological changes were studies using a light
microscope (Nikon). (a) Time course morphological changes of WEHI-3B JCS cells (magniﬁcation, ×200). Black bars represent 50 μm.
(b) Induction of adherence of WEHI-3B JCS cells after exposure to rSj16. The data were expressed as mean ± SEM, n = 3.
∗∗P<. 01;
∗∗∗P<. 001 as compared with that of untreated group. (c)–(e) Modiﬁed Wright Giemsa staining of WEHI-3B JCS cells 72 hours post
treatment (magniﬁcation, ×400). Black bars represent 25μm. Data are representative of three individual experiments.
[18]. In addition, TNF-α has been identiﬁed as the active
substance in PMA-induced macrophage diﬀerentiation of
WEHI-3B JCS cells [2]. Thus, we investigated the eﬀects
of rSj16 on the expression of IL-1α,I L - 1 β,a n dT N F - α of
WEHI-3B JCS cells. Untreated WEHI-3B JCS cells expressed
little IL-1α and IL-1β (both less than 1pg/ml in the culture
media, Figures 6(b) and 6(c)) and expressed low level of
TNF-α (Figure 6(a)). Treatment of WEHI-3B JCS cells with
rSj16, but not rGST, caused marked time-dependent up-
regulation of the expression of these three cytokines (Figures
6(a)–6(c)). The levels of IL-1α,I L - 1 β,a n dT N F - α in the
culture supernatants increased to 60.77pg/ml, 8.57pg/ml,
and 97.15pg/ml, respectively, after 3 days exposure to rSj16
(Figures 6(a)–6(c)).
3.7. Diﬀerentiation-Inducing Eﬀect of rSj16 on WEHI-3B JCS
Cells is not Attributable to Endogenous Production of IL-1α,
IL-1β,a n dT N F - α. To investigate the role of endogenous
IL-1α,I L - 1 β,a n dT N F - α in the rSj16-induced WEHI-3B
JCS cells diﬀerentiation, speciﬁc antibodies were adopted
to neutralize each cytokine, respectively. The neutralizing
ability of the antibodies was veriﬁed using D10.G4.1 cell
proliferation assay for anti-IL-1α and anti-IL-1β, and using
L929 cell cytolytic assay for anti-TNF-α (data not shown).
Before evaluating the blocking activity of the antibodies
on rSj16-mediated diﬀerentiation, an initial experiment
was performed to test the eﬀect of each antibody on the
proliferation (by MTT assay) and morphological changes of
WEHI-3B JCS cells, and the results indicated that the eﬀectJournal of Biomedicine and Biotechnology 7
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Figure 4: Induction of macrophage marker expression on WEHI-3B JCS cells by rSj16. WEHI-3B JCS cells were treated for 72 hours in the
presence of 0.5μg/ml rSj16 (rSj16), 0.5μg/ml rGST (rGST), or medium alone (untreated) and then analyzed for expression of F4/80 and
Gr-1 using ﬂow cytometry. (a) Red line indicates isotype-matched control antibody; black line, F4/80 or Gr-1. (b) Column indicates mean
± SEM of four independent experiments.
∗P<. 05 as compared with that of untreated group.8 Journal of Biomedicine and Biotechnology
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Figure 5: rSj16 induced WEHI-3B JCS cells showed phagocytic activity. WEHI-3B JCS cells were treated for 72 hours with 0.5μg/ml rSj16
(rSj16, (c)), 0.5μg/ml rGST (rGST, (b)), or medium alone (untreated, (a)) and then analyzed for the capacity of yeast-ingesting. (a)–(c)
Arrows indicate the yeast-ingesting cells. White bars represent 50μm (magniﬁcation, ×400). (d) Percentage of phagocytic cells after 72hours
treatment. The results are the mean ± SEM of three independent experiments.
∗∗∗P<. 001 as compared with that of untreated group.
of each of them neither inhibited the proliferation nor
aﬀected morphological changes of WEHI-3B JCS cells when
being used as high as 10μg/ml (data not shown). The
blocking eﬀect of the antibodies on rSj16-induced WEHI-
3B JCS diﬀerentiation was evaluated by both MTT assay and
morphological studies as described in Section 2. The results
showed that none of them, no matter be used separately
or combined, could block rSj16-mediated morphological
changes and antiproliferation (data not shown) of WEHI-3B
JCS cells at the concentration being used as high as 10μg/ml.
Therefore, it is suggested that rSj16-induced WEHI-3B
JCS diﬀerentiation does not depend on the endogenous
production of IL-1α,I L - 1 β,a n dT N F - α.
3.8. Eﬀect of rSj16 on IL-3, M-CSF, or G-CSF Induced
Proliferation and Diﬀerentiation of Mouse Bone Marrow
Cells. As mentioned above, rSj16 could induce macrophage
diﬀerentiation of WEHI-3B JCS cells (Figures 3–5). Since
the WEHI-3B JCS cells are derived from bone marrow
progenitors [3], it raised a question whether rSj16 can
also aﬀect hematopoiesis of bone marrow cells. It is well
characterized that hematopoietic growth factors such as G-
CSF, M-CSF, and IL-3 can regulate the proliferation and
diﬀerentiation of bone marrow cells and stimulate related
colony formation [19, 20]. To test the eﬀects of rSj16 on
hematopoiesis, mouse bone marrow cells were cultured in
semisolid agar cultures containing optimal G-CSF, M-CSF,
or IL-3 in the presence or absence of 0.5μg/ml of rSj16.
After treated with G-CSF or M-CSF, signiﬁcant increases
of CFU-G colonies (Figure 7(a)) or CFU-M colonies
(Figure 7(b)) were found in the corresponding plates. Addi-
tion of rSj16 into the culture before the treatment of G-CSF
greatly reduced the colony counts of G-CSF-induced CFU-G
(Figure 7(a)).ItisinterestingthatthepresenceofrSj16inthe
culture did not aﬀect the number of M-CSF-induced CFU-
M colonies (Figure 7(b)) but only increased the compactness
of the cells within the colonies (Figure 8(b)).
As expected, colonies CFU-M, CFU-G, and CFU-GM
were signiﬁcantly induced following seven days culture with
IL-3 (Figure 7(c)). However, when rSj16 was preadded into
the culture one hour before the IL-3 treatment, the total
coloniesandthecolonycountsofCFU-GandCFU-GMwereJournal of Biomedicine and Biotechnology 9
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Figure 6: Eﬀect of rSj16 on IL-1α, IL-1β,a n dTNF-α production from WEHI-3B JCS cells. WEHI-3B JCS cells were treated with 0.5μg/ml
rSj16 (rSj16), 0.5μg/ml rGST (rGST), or medium alone (untreated), and then the culture supernatants were collected at diﬀerent time as
indicated for the detection of TNF-α (a), IL-1α (b), and IL-1β (c) by Sandwich ELISA. Values represent mean ± SEM of three independent
experiments.
∗∗∗P<. 001;
∗∗P<. 01, as compared with that of untreated group.
signiﬁcantly decreased, while the colony counts of CFU-M
wereincreased(Figure 7(c)).Besides,justassimilarasshown
in Figure 8, the cells within CFU-M colonies in the presence
of rSj16 also became more compact than those treated with
IL-3 alone (data not shown).
There were no colonies induced when the mouse bone
marrow cells were treated with PBS alone 0.5μg/ml of rSj16
alone, or 0.5μg/ml of rGST alone (data not shown).
4. Discussion
Sj16 is a secretory protein produced by S. japonicum.I t
has 100% identity with the protein sequence of the anti-
inﬂammatory protein Sm16 which is abundantly present in
the excretory secretions of schistosomulae of S. mansoni [21,
22]. Previous studies reported that Sm16 could suppress the
host immune responses by inhibiting the antigen-induced10 Journal of Biomedicine and Biotechnology
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Figure 7: Eﬀect of rSj16 on IL-3, M-CSF, or G-CSF induced colony formation of mouse bone marrow cells. M o u s eb o n em a r r o wc e l l sw e r e
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lymphoproliferation and suppressing the IL-2 production
from lymphocytes [22]. Sm16 could also suppress LPS-
induced neutrophil inﬁltration and downregulate produc-
tion of the proinﬂammatory cytokines [23]. In addition, a
single intradermal injection of a full-length cDNA of Sm16
resulted in a signiﬁcant suppression of cutaneous inﬂam-
mation [24]. By using recombinant protein obtained from
E. coli, we also demonstrated that rSj16 dramatically sup-
pressed the thioglycollate-mediated recruitment of leuko-
cytes to the peritoneal cavity of BALB/c mice and suppressed
thioglycollate-induced peritoneal macrophages maturation,
accompanied by marked upregulation of IL-10 and IL-1
receptor antagonist transcripts, and down-regulation of IL-
12p35, IL-1β, and MIP-2 transcripts in peritoneal cells [11].Journal of Biomedicine and Biotechnology 11
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Figure 8: Eﬀect of rSj16 on morphology of M-CSF-induced CFU-M colonies after hematoxylin staining. M o u s eb o n em a r r o wc e l l sw e r et r e a t e d
with M-CSF in the presence of rSj16 (b), rGST (c),o rP B S( a )a sd e s c r i b e di nFigure 7.T h eb l a c kb a r sr e p r e s e n t5 0μm (magniﬁcation, ×
100). The photos are representatives of three individual experiments.
Further analysis revealed that rSj16 also inhibited both
humoral and cellular immunity to heterologous antigens
using BALB/c mouse model (Hu et al., unpublished data).
Thus, it is evident that rSj16 retain an immunomodulatory
function.
In this study, to extend our knowledge of the
immunomodulatory function of rSj16, we ﬁrst investigated
the eﬀects of rSj16 on the proliferation and diﬀerentiation
of the leukemia cell line WEHI-3B JCS. Our data indicated
that rSj16 could inhibit the growth of WEHI-3B JCS cells
in a time- and concentration-dependent manner (Figure 1).
Interestingly, it is obvious that the rSj16-mediated inhibition
of WEHI-3B JCS cell proliferation is not attributable to its
cytotoxic eﬀect on the cell, since the viability of the WEHI-
3B JCS cells was not aﬀected by the rSj16 treatment. Further
studies indicated that rSj16 also induced macrophage
morphological changes of the WEHI-3B JCS cells (Figure 3),
companied with markedly decrease of the cells in the S
phases and concomitant accumulation in the proportion of
those in G1/G0 and G2/M phase (Figure 2). These results
may suggest that rSj16 induces macrophage diﬀerentiation
of the WEHI-3B JCS cells.
Membrane antigens serve as excellent markers of murine
macrophage diﬀerentiation in vivo and in vitro [25]. To
conﬁrm macrophage diﬀerentiation of the WEHI-3B JCS
cells, we analyzed the membrane antigens by ﬂow cytometry.
Among the two antigens being analyzed, the F4/80 is
expressed by a majority of mature macrophages and is
the best marker for this population of cells [26], while
Gr-1 is expressed by bone marrow granulocytes as well
as on peripheral neutrophils [27]. As expected, our data
showed that rSj16 could stimulate the expression of F4/80
on the WEHI-3B JCS cells surface but not Gr-1 (Figure 4),
thus supporting the macrophage diﬀerentiation of the cells.
Subsequently, this diﬀerentiated WEHI-3B JCS cells have
been veriﬁed to be functional, as they acquired the yeast-
phagocytizing activity after rSj16 treatment (Figure 5).
It is well known that LPS could induce macrophage
diﬀerentiation of certain leukemia cells [28, 29]. In order
to exclude the possible contamination of endotoxins during
preparation of rSj16, the puriﬁed proteins were passed
through a Detoxi-Gel AﬃnityPak polymyxin B column
(Pierce) to eliminate endotoxins. The absence of endotoxins
in the protein samples was further conﬁrmed by Limulus
amebocyte lysate test (sensitivity 0.25EU/ml, Associates of
Cape Cod). Besides, the rGST prepared as the same way as
rSj16wasservedasnegativecontrolinthewholestudy.Thus,
in this study, the rSj16-induced macrophage diﬀerentiation
should not due to the endotoxins contamination.
Cytokines, such as IL-l, leukemia inhibitory factory,
TNF-α , and IL-4, have been shown to regulate the growth
and diﬀerentiation of hematopoietic cell [30, 31]. Previous
studies reported that PMA-induced macrophage diﬀerenti-
ation of WEHI-3B JCS cells was mediated by endogenous
production of TNF-α, as the diﬀerentiation-inducing eﬀect
of PMA could be prevented by neutralizing anti-TNF-α
antibodies [2]. Further studies showed that macrophage
diﬀerentiation of WEHI-3B JCS cells could be also induced
by TNF-α,I L - 1 α,o rI L - 1 β. We were thereby interested in
whether rSj16-induced WEHI-3B JCS cells diﬀerentiation
was results of endogenous production of TNF-α,I L - 1 α
or IL-1β. Unexpectedly, although the production of these
three cytokines has been upregulated after rSj16 treatment
(Figure 6), they were obviously not involved in the rSj16-
induced WEHI-3B JCS diﬀerentiation, as none of the anti-
IL-1α, anti-IL-1β, anti-TNF-α, or these three antibodies
together could prevented the activity of rSj16 (data not
shown). Thus, these results indicated that rSj16 induce
WEHI-3B JCS cells diﬀerentiation through some other
mechanisms. However, currently we don’t have information
about the mechanisms. This will be addressed in our
following studies.
TheWEHI-3BJCScelllineisasubcloneisolatedfromthe
murine myelomonocytic leukemia WEHI-3B cell line and
therefore possesses some certain features of myelomonocytic
progenitor cells [2]. This cell line has been widely used
to be a useful model in the study of hematopoietic cell
diﬀerentiation [2–4, 32, 33]. In the present study, we
have demonstrated that rSj16 could induce macrophage
diﬀerentiation of the WEHI-3B JCS cell (Figures 3–5). It is
thus reasonable to investigate the regulatory eﬀect of rSj16
on the mouse hematopoiesis. Our results revealed that rSj1612 Journal of Biomedicine and Biotechnology
could suppress G-CSF-induced CFU-G colony formation
(Figure 7(a)) and suppress IL-3-induced CFU-G and CFU-
GM colony formation (Figure 7(c)). On the other hand,
although rSj16 alone did not induce any colony formation
of the mouse bone marrow cells, we demonstrated that rSj16
could increase the number of IL-3-induced CFU-M colony
formation (Figure 7(c)). This result corresponded with our
previous observation that rSj16 induces macrophage dif-
ferentiation of WEHI-3B JCS cell (Figures 3–5). However,
unexpectedly, the addition of rSj16 into the culture did
not aﬀect the number of M-CSF-induced CFU-M colonies
(Figure 7(b)). A possible interpretation is that M-CSF is a
potent inducer of macrophage diﬀerentiation which may
mask the inducing eﬀect of rSj16.
Furthermore, it is very interesting that the macrophages
within the CFU-M colonies induced by IL-3 along with rSj16
(data not shown) and M-CSF along with rSj16 (Figure 8(b))
became more compact than those induced with IL-3 (data
not shown) or M-CSF (Figure 8(a)) alone, which suggested
that the diﬀerentiated macrophages after rSj16 treatment
may lose the ability of migration. This result may indicate
that although rSj16 induced macrophage diﬀerentiation of
WEHI-3BJCScellandincreasedthenumberofIL-3-induced
CFU-M colony formation of mouse bone marrow cells,
the diﬀerentiated macrophage cells may not display full
functions as normal mature macrophages. As the inhibition
of antigen-presenting cell migration has been proved to
be a strategy for the schistosomes to escape host immune
system [7], our results may further suggest that Sj16 helps
the parasite to survive from host immune attack. However,
further studies are needed to support this postulation and
explore the potential mechanisms.
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